Clinical Trial Update: Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study) [NA]

View source ↗

Summary

This is a single-center randomized, sham-controlled trial evaluating argon plasma coagulation endoscopic therapy for gastroesophageal reflux disease. Recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: GERD | NA | Status: RECRUITING